| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Research and development | $2.4M-41.8% | $4.1M-73.4% | $15.5M+53.8% | $10.1M-4.9% | $10.6M-52.1% | $22.1M |
| General and administrative | $7.0M+8.2% | $6.4M+18.2% | $5.5M+21.7% | $4.5M-15.0% | $5.3M+16.3% | $4.5M |
| Total operating expenses | $9.4M-11.3% | $10.6M-49.6% | $20.9M+43.9% | $14.6M-8.2% | $15.9M-40.5% | $26.6M |
| Loss from operations | -$9.4M+11.3% | -$10.6M+49.5% | -$20.9M-45.0% | -$14.4M+8.6% | -$15.8M+40.8% | -$26.6M |
| Interest income | $182K+297.0% | $46K-78.2% | $210K+54.8% | $136K+79.2% | $76K-15.1% | $89K |
| Interest expense | -$786K-2534.9% | -$30K+2.5% | -$31K-102.5% | -$15K+4.1% | -$16K-47.5% | -$11K |
| Foreign currency exchange, net | -$13K+47.6% | -$25K | — | — | — | — |
| Total other income (expense), net | -$617K-6676.8% | -$9K-103.7% | $249K+88.2% | $132K+122.8% | $59K-71.8% | $211K |
| Loss before income taxes | -$10.0M+5.6% | -$10.6M+48.8% | -$20.7M-44.6% | -$14.3M+9.1% | -$15.7M+40.6% | -$26.4M |
| Income tax benefit | $137K | — | — | — | — | — |
| Net loss | -$9.8M+6.9% | -$10.6M+48.8% | -$20.7M-44.6% | -$14.3M+9.1% | -$15.7M+40.6% | -$26.4M |
| Basic net loss per share | -$4.56+90.5% | -$47.88-421.6% | -$9.18-29.1% | -$7.11+12.1% | -$8.09 | — |
| Diluted net loss per share | -$4.56-185.0% | -$1.60+82.6% | -$9.18-29.1% | -$7.11 | — | — |
| Weight average shares outstanding, basic | 2.2M+877.2% | 221K-90.2% | 2.2M+12.0% | 2.0M+3.4% | 1.9M | — |
| Weight average shares outstanding, diluted | 2.2M+877.2% | 221K-90.2% | 2.2M+12.0% | 2.0M | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.